Both CelGro Nerve and ATI results were due tin 3Q19, so I'd hope J&J ATI trials out before end of October. I suspect its more a case of management preparing the report. Whilst CelGro Nerve trial update on all patients will hopefully move the price up, I suspect J&J ATI trials will be the real mkt mover. J&J would be short-sighted not to form a partnership with poison pill bindings to discourage a takeover of OCC by a rival. Personally if I ran J&J I'd snap them up at the cheap prevailing price. Not the best for long-term holders though.
- Forums
- ASX - By Stock
- OCC
- Upcoming announcements
Upcoming announcements, page-176
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.54M |
Open | High | Low | Value | Volume |
37.0¢ | 37.3¢ | 37.0¢ | $8.069K | 21.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 32843 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 35726 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32843 | 0.365 |
8 | 119640 | 0.360 |
5 | 73319 | 0.355 |
6 | 107025 | 0.350 |
2 | 31886 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 35726 | 1 |
0.375 | 10567 | 3 |
0.380 | 10671 | 1 |
0.390 | 79373 | 6 |
0.395 | 30226 | 2 |
Last trade - 12.41pm 28/08/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online